References
- Chen N, Nusbaum P, Halbwachs-Mecarelli L, Lesavre P. Light chain composition of IgA1 and in vitro IgA1 synthesis in IgA nephropathy. Nephrol Dial Transplant 1991; 6: 846–850
- Chui S H, Lewis W HP, Lam C WK, Lai K N. Analysis of charge of kappa and lambda chin-containing serum IgA by immunoblotting and densitometry. Clin Biochem 1993; 25: 97–100
- Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709–727
- Gallo G R, Caulin-Glaser T, Emancipator S N, Lamm M E. Nephritogenicity and differential distribution of glomerular immune complexes related to immunogen charge. Lab Invest 1983; 48: 353–362
- Gregory R L, Rundegern J, Arnold R R. Separation of human IgA1 and IgA2 using jacalin-agarose chromatography. J Immunol Methods 1987; 99: 101–106
- Harada T, Hobby P, Courteau M, Knight J F, Williams D G. Charge distribution of plasma IgA in IgA nephropathy. Clin Exp Immunol 1989; 77: 211–214
- Issacs K L, Miller F. Role of antigen size and charge in immune complex glomerulonephritis: Active induction of disease with dextran and its derivatives. Lab Invest 1982; 47: 198–205
- Lai K N, Chui S H, Lai F M, Lam C WK. Predominant synthesis of IgA with lambda chain in IgA nephropathy. Kidney Int 1988; 33: 584–589
- Lai K N, Leung J CK. Heat-aggregated IgA prepared from patients with IgA nephropathy increases calcium mobilization and superoxide product-ion of human neutrophils in vitro. Nephron 1993; 64: 129–135
- Lai K N, Wang A YM. IgA nephropathy–a common nephritis leading to end-stage renal failure. Int J Artif Organs 1994; 17: 457–460
- Lai K N, Chui S H, Lewis W HP, Poon A SY, Lam C WK. Charge distribution of IgA-lambda in IgA nephropathy. Nephron 1994; 66: 38–44
- Lai K N, Leung J CK, Li P KT. Heat aggregated IgA prepared from patients with IgA nephropathy increases priming of human neutrophils to produce inositol triphosphate following FMLP stimulation in vitro. Nephron 1995; 69: 1–8
- Lai K N, To W Y, Leung J CK, Li P KT. Increased binding of polymeric IgA-lambda isolated from patients with IgA nephropathy by cultured human mesangial cells. Kidney Int 1996; 49: 839–845
- Mestecky J, Tomana M, Crowley-Nowick P A, Moldo-veanu Z, Julian B A, Jackson S. Defective galactosy-lation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 1993; 104: 172–182
- Monteiro R C, Halbwachs-Mecarelli L, Roque-Barreira M C, Noel L H, Berger J, Lesavre P. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985; 28: 666–671
- Monteiro R C, Chevailler A, Noel L H, Lesavre P. Serum IgA preferentially binds to cationic polypeptides in IgA nephropathy. Clin Exp Immunol 1988; 73: 300–306
- Suen K KY, Lewis W HP. Focused antigen capture assay. Electrophoresis 1994; 15: 1120–1124